Dual-targeted and esterase-responsive cyclodextrin-based host-guest nanocomposites for enhanced antitumor therapy
Colloids and Surfaces B: Biointerfaces · 2025
DOI: 10.1016/j.colsurfb.2024.114371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colloids and Surfaces B: Biointerfaces, 2025. Verfasst von Li Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China. Hauptthemen laut MEDLINE: Nanocomposites, Esterases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Conventional chemotherapy drugs are difficult to effectively target tumor tissue, leading to poor treatment outcomes and side effects. Actively targeted and stimuli-responsive nanomedicine greatly improves this situation, allowing for more precise drug accumulation at tumor sites. Herein, carboxymethyl-β-cyclodextrin (CMCD) - based host-guest nanocomposites (NPs) encapsulating hydroxycamptothecin (HCPT) were fabricated, which responded to esterase and had the function of targeting CD 44 receptors and the nucleus. PS-CMCD was firstly synthesized through an amide reaction of protamine (PS) and CMCD to enhance the function of penetrating membrane and nuclear localization. PS-CMCD/HCPT/HA NPs were then prepared by the host-guest complexation of PS-CMCD and HCPT and followed by surface modification of hyaluronic acid (HA) with CD44 receptor-targeting properties. The successful inclusion was also validated through computer simulation. The obtained nanocomposites displayed the esterase-responsive release behaviors of HCPT. Moreover, the synthesized PS-CMCD/HCPT/HA NPs enhanced the intracellular drug uptake due to the tumor cell- and nuclear-mediated targeting. In addition, in vivo application exhibited that PS-CMCD/HCPT/HA NPs realized good antitumor effects. These findings suggested its potential for targeted delivery and more effective tumor therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China.
- College of Medical Devices, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.
- Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China. Electronic address: zhangpengspu@163.com.
- Wuya College of Innovation, Shenyang Pharmaceutical University, No. 103, Wenhua Road, Shenyang 110016, China; College of Medical Devices, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China. Elec…
- Zhejiang Provincial Key Laboratory of Imaging Diagnosis and Minimally Invasive Intervention Research, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui 323000, China. Electronic address: jjstcty@wmu.ed…
Zitieren
APA
Qin, L., Tu, J., Zhao, J., Zhang, Y., Li, T., Zhang, Y., Zhang, P., Ling, G., & Ji, J. (2025). Dual-targeted and esterase-responsive cyclodextrin-based host-guest nanocomposites for enhanced antitumor therapy. Colloids and Surfaces B: Biointerfaces. https://doi.org/10.1016/j.colsurfb.2024.114371
Vancouver
Qin L, Tu J, Zhao J, Zhang Y, Li T, Zhang Y, et al. Dual-targeted and esterase-responsive cyclodextrin-based host-guest nanocomposites for enhanced antitumor therapy. Colloids and Surfaces B: Biointerfaces. 2025. doi:10.1016/j.colsurfb.2024.114371
BibTeX
@article{Qin2025,
author = {Qin, Li and Tu, Jianfei and Zhao, Jiawei and Zhang, Yuanke and Li, Tiancheng and Zhang, Yuqi and Zhang, Peng and Ling, Guixia and Ji, Jiansong},
title = {Dual-targeted and esterase-responsive cyclodextrin-based host-guest nanocomposites for enhanced antitumor therapy},
journal = {Colloids and Surfaces B: Biointerfaces},
year = {2025},
doi = {10.1016/j.colsurfb.2024.114371}
}
EUVIMED